Year-and-a-Half Old, Dried Echinacea Roots Retain Cytokine-Modulating Capabilities in an in vitro Human Older Adult Model of Influenza Vaccination

Abstract

Alcohol tinctures prepared from aged Echinacea roots are typically taken for preventing or treating upper respiratory infections, as they are purported to stimulate immunity in this context. The effects of long-term (> 1 year) dry storage on the capabilities of Echinacea spp. roots from mature individuals to modulate cytokine production are unknown. Using an older human adult model of influenza vaccination, we collected peripheral blood mononuclear cells from subjects 6 months post-vaccination and stimulated them in vitro with the two Type A influenza viruses contained in the trivalent 2004 - 2005 vaccine with a 50 % alcohol tincture prepared from the roots of one of seven Echinacea species: E. angustifolia, E. pallida, E. paradoxa, E. purpurea, E. sanguinea, E. simulata, and E. tennesseensis. Before being processed into extracts, all roots had been stored under dry conditions for sixteen months. Cells were cultured for 48 hours; following incubation, supernatants were collected and assayed for interleukin-2, interleukin-10, and interferon-γ production, cytokines important in the immune response to viral infection. Four species (E. angustifolia, E. purpurea, E. simulata, E. tennesseensis) augmented IL-10 production, diminished IL-2 production, and had no effect on IFN-γ production. Echinacea pallida suppressed production of all cytokines; E. paradoxa and E. sanguinea behaved similarly, although to a lesser extent. The results from these in vitro bioactivity assays indicate that dried Echinacea roots stored for sixteen months maintain cytokine-modulating capacities. Our data support and extend previous research and indicate that tinctures from different Echinacea species have different patterns of immune modulation; further, they indicate that certain species may be efficacious in the immune response to viral infection.

Key words

Echinacea angustifolia - Echinacea pallida - Echinacea paradoxa - Echinacea purpurea - Echinacea sanguinea - Echinacea simulata - Echinacea tennesseensis - interleukin-2 - interleukin-10 - interferon-gamma - influenza - tincture

References

• 1 Barnes P M, Powell-Griner E, McFann K, Nahin R L. Complementary and alternative medicine use among adults: United States, 2002.  Adv Data. 2004;  343 1-19
• 2 Bent S RK. Commonly used herbal medicines in the United States: a review.  Am J Med. 2004;  116 478-85
• 3 Barrett B P. Medicinal properties of Echinacea: a critical review.  Phytomedicine. 2003;  10 66-86
• 4 Hwang S A, Dasgupta A, Actor J K. Cytokine production by non-adherent mouse splenocyte cultures to Echinacea extracts.  Clin Chim Acta. 2004;  343 161-6
• 5 Senchina D S, McCann D A, Asp J M, Johnson J A, Cunnick J E, Kaiser M S. et al . Changes in immunomodulatory properties of Echinacea spp. root infusions and tinctures stored at 4 °C for four days.  Clin Chim Acta. 2005;  355 67-82
• 6 Turner R B, Bauer R, Woelkart K, Hulsey T C, Gangemi J D. An evaluation of Echinacea angustifolia in experimental rhinovirus infections.  N Engl J Med. 2005;  353 341-8
• 7 Kabganian R, Carrier D J, Sokhansanj S. Drying of Echinacea angustifolia roots.  J Herbs Spices Med Plants. 2002;  10 1-9
• 8 Kabganian R, Carrier D J, Sokhansanj S. Physical characteristics and drying rate of Echinacea root.  Drying Technol. 2002;  20 637-50
• 9 Kim H O, Durance T D, Scaman C H, Kitts D D. Retention of alkamides in dried Echinacea purpurea .  J Agric Food Chem. 2000;  48 4187-92
• 10 Kim H O, Durance T D, Scaman C H, Kitts D D. Retention of caffeic acid derivatives in dried Echinacea purpurea .  J Agric Food Chem. 2000;  48 4182-6
• 11 Li T SC, Wardle D A. Effects of root drying temperature and moisture content on the levels of active ingredients in Echinacea roots.  J Herbs Spices Med Plants. 2001;  8 15-21
• 12 Stuart D L, Wills R BH. Effect of drying temperature on alkamides and cichoric acid concentrations of Echinacea purpurea .  J Agric Food Chem. 2003;  51 1608-10
• 13 Wills R BH, Stuart D L. Effect of handling and storage on alkylamides and cichoric acid in Echinacea purpurea .  J Sci Food Agric. 2000;  80 1402-6
• 14 Perry N B, van Klink J W, Burgess E J, Parmenter G A. Alkamide levels in Echinacea purpurea: effects of processing, drying, and storage.  Planta Med. 2000;  66 54-6
• 15 Jiang B, Yang H, Nuntanakorn P, Balick M J, Kronenberg F, Kennelly E J. The value of plant collections in ethnopharmacology: a case study of an 85-year-old black cohosh (Actaea racemosa L.) sample.  J Ethnopharmacol. 2005;  96 521-8
• 16 Binns S E, Arnason J T, Baum B R. Phytochemical variation within populations of Echinacea angustifolia (Asteraceae).  Biochem Syst Ecol. 2002;  30 837-54
• 17 Gray D E, Pallardy S G, Garrett H E, Rottinghaus G E. Acute drought stress and plant age effects on alkamide and phenolic acid content in purple coneflower roots.  Planta Med. 2003;  69 50-5
• 18 Clifford L J, Nair M G, Rana J, Dewitt D L. Bioactivity of alkamides isolated from Echinacea purpurea (L.) Moench.  Phytomedicine. 2002;  9 249-53
• 19 Raso G M, Pacilio M, Di Carlo G, Esposito E, Pinto L, Meli R. In-vivo and in-vitro anti-inflammatory effect of Echinacea purpurea and Hypericum perforatum .  J Pharm Pharmacol. 2002;  54 1379-83
• 20 Sestakova H, Turek B. In: Miller SC, editor Echinacea: the genus Echinacea. Boca Raton; CRC Press 2004
• 21 Di Carlo G, Nuzzo I, Capasso R, Sanges M R, Galdiero E, Capasso F. et al . Modulation of apoptosis in mice treated with Echinacea and St. John's wort.  Pharmacol Res Commun. 2003;  48 273-7
• 22 Bodinet C, Mentel R, Wegner U, Lindequist U, Teuscher E, Freudenstein J. Effect of oral application of an immunomodulating plant extract on influenza virus type A infection in mice.  Planta Med. 2002;  68 896-900
• 23 Bernstein E, Gardner E, Abrutyn E, Gross P, Murasko D. Cytokine production after influenza vaccination in a healthy elderly population.  Vaccine. 1998;  16 1722-31
• 24 Kraus G A, Bae J. Synthesis of N-(2-methylpropyl)-2-undecene-8,10-diynamide, a novel constituent of Echinacea angustifolia .  Tetrahedron Lett. 2003;  44 5505-6
• 25 Wu L, Bae J, Kraus G, Wurtele E S. Diacetylenic isobutylamides of Echinacea: synthesis and natural distribution.  Phytochemistry. 2004;  65 2477-84
• 26 Kohut M L, Arntson B A, Lee W, Rozeboom K, Yoon K J, Cunnick J E. et al . Moderate exercise improves antibody response to influenza immunization in older adults.  Vaccine. 2004;  22 2298-306
• 27 Smith K A. Interleukin 2.  Annu Rev Immunol. 1984;  2 319-33
• 28 Saurwein-Teissl M, Steger M M, Gluck R, Cryz S, Grubeck-Loebenstein B. Influenza vaccination in a healthy geriatric population: preferential induction of antibodies specific for the H3N2 influenza strain despite equal T cell responsiveness to all vaccine strains.  Vaccine. 1998;  16 196-200
• 29 Lindenmuth G F, Lindenmuth E B. The efficacy of Echinacea compound herbal tea preparation on the severity and duration of upper respiratory and flu symptoms: a randomized, double-blind placebo-controlled study.  J Altern Complement Med. 2000;  6 327-34
• 30 Bruno J J, Ellis J J. Herbal use among US elderly: 2002 National Health Interview Survey.  Ann Pharmacother. 2005;  39 643-8
• 31 Kohut M L, Senchina D S. Reversing age-associated immunosenescence via exercise.  Exerc Immunol Rev. 2004;  10 6-41
• 32 Goel V, Lovlin R, Chang C, Slama J V, Barton R, Gahler R. et al . A proprietary extract from the echinacea plant (Echinacea purpurea) enhanced systemic immune response during a common cold.  Phytother Res. 2005;  19 689-94
• 33 Ouyang Q, Cicek G, Westendorp R GJ, Cools H JM, van der Klis R J, Remarque E J. Reduced interferon-γ production in elderly people following in vitro stimulation with influenza vaccine and endotoxin.  Mech Ageing Dev. 2000;  121 131-7
• 34 Bernstein E, Kaye D, Abrutyn E, Gross P, Dorfman M, Murasko D M. Immune response to influenza vaccination in a large healthy elderly population.  Vaccine. 1999;  17 82-94
• 35 Deng Y, Jing Y, Campbell A E, Gravenstein S. Age-related impaired type 1 T cell responses to influenza: reduced activation ex vivo, decreased expansion in CTL culture in vitro, and blunted response to influenza vaccination in vivo in the elderly.  J Immunol. 2004;  172 3437-46
• 36 Dobber R, Tielemans M, Nagelkerken L. The in vivo effects of neutralizing antibodies against IFN-gamma, IL-4, or IL-10 on the humoral immune response in young and aged mice.  Cell Immunol. 1995;  160 185-92
• 37 Binns S E, Hudson J, Merali S, Arnason J T. Antiviral activity of characterized extracts from Echinacea spp. (Heliantheae:Asteraceae) against Herpes simplex virus (HSV-I).  Planta Med. 2002;  68 780-3
• 38 Pellati F, Benvenuti S, Melegari M, Lasseigne T. Variability in the composition of anti-oxidant compounds in Echinacea species by HPLC.  Phytochem Anal. 2005;  16 77-85
• 39 Speroni E, Govoni P, Guizzardi S, Renzulli C, Guerra M C. Anti-inflammatory and cicatrizing activity of Echinacea pallida Nutt. root extract.  J Ethnopharmacol. 2002;  79 265-72
• 40 Barnes J, Anderson L A, Gibbons S, Phillipson J D. Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt., Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties.  J Pharm Pharmacol. 2005;  57 929-954